Fulvia Veronese

Author PubWeight™ 14.22‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. MMWR Recomm Rep 2005 5.03
2 In vitro and in vivo: the story of nonoxynol 9. J Acquir Immune Defic Syndr 2005 1.99
3 Does patient sex affect human immunodeficiency virus levels? Clin Infect Dis 2002 1.72
4 Greentree white paper: sexual violence, genitoanal injury, and HIV: priorities for research, policy, and practice. AIDS Res Hum Retroviruses 2012 1.52
5 Pharmacokinetics and pharmacodynamics in HIV prevention; current status and future directions: a summary of the DAIDS and BMGF sponsored think tank on pharmacokinetics (PK)/pharmacodynamics (PD) in HIV prevention. AIDS Res Hum Retroviruses 2013 0.98
6 Role of oral pre-exposure prophylaxis (PrEP) in current and future HIV prevention strategies. Curr HIV/AIDS Rep 2014 0.89
7 Mucosal immunity in the male and female reproductive tract and prevention of HIV transmission. Am J Reprod Immunol 2011 0.78
8 Hormone regulation of the mucosal environment in the reproductive tract and the prevention of HIV infection. Am J Reprod Immunol 2014 0.76
9 Critical need for appropriate mucosal sample collection to determine relational animal pharmacokinetic-pharmacodynamic models in HIV prevention. AIDS Res Hum Retroviruses 2013 0.75
10 2010 Workshop: Mucosal immunity in the male and female reproductive tract and prevention of HIV transmission. AIDS Res Hum Retroviruses 2011 0.75
11 Antigen-presenting cells in HIV pathogenesis and therapy: summary of the October 17-18, 2002, Think Tank meeting. Clin Immunol 2002 0.75